Role of neo-adjuvant chemotherapy followed by surgery in cervical cancer: a review

Ganesh Bharaswadkar

doi:10.18203/2320-1770.ijrcog20203884

Authors

Ganesh Bharaswadkar Department of Obstetrics and Gynecology, BDF Hospital, Bahrain

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20203884

Keywords:

Cervical cancer, Neo-adjuvant chemotherapy, Surgery

Abstract

Incidence of cervical cancer is predominantly found in developing countries. In Indian set up, it is most commonly found in rural locations in younger population. Chemotherapy was initially introduced for the treatment of recurrent/metastatic cervix cancer and has subsequently been explored in primary treatment either as neo-adjuvant prior to radiation or surgery in an attempt to reduce the incidence of loco-regional recurrence. The review study tries to evaluate the role of neoadjuvant chemotherapy (NACT) followed by surgery in cervical cancer management. Randomized trials and meta-analysis were analysed. Most of them used short course chemotherapy course of 4-6 weeks followed by surgery. patients with high risk pathological features received postoperative RT. The results of trials indicated significant reduction in the risk of death with NACT, but there were few differences between the trials. NACT followed by surgery is found to be associated with an improved response rate and progression-free survival. However, the impact on overall survival remains to be confirmed.

Metrics

Metrics Loading ...

Author Biography

Ganesh Bharaswadkar, Department of Obstetrics and Gynecology, BDF Hospital, Bahrain

Obstetrics and Gynecology

Senior specialist

References

Prakash G, Kumar L. Chemotherapy for cervical cancer: an update; in Rajaram S (ed): cancer cervix, edition 1st. New Delhi, Jaypee Brothers Medical Publishers Pvt. Ltd.; 2011:214.

Sharma A, Kumar L. Cancer of the cervix: what is better?. Natl Med J India. 2018;31:97-8.

Sananes C, Giaroli A, Soderini A, Guardado N, Snaidas L, Bermudez A, et al. Neoadjuvant chemotherapy followed by radical hysterectomy and postoperative adjuvant chemotherapy in the treatment of carcinoma of the cervix uteri: long-term follow-up of a pilot study. Eur J Gynaecol Oncol. 1998;19:368-73.

Hwang YY, Moon H, Cho SH, Kim KT, Moon YJ, Kim SR, et al. Ten-year survival of patients with locally advanced, stage ib-iib cervical cancer after neoadjuvant chemotherapy and radical hysterectomy. Gynecol Oncol. 2001;82:88-93.

Chang TC, Lai CH, Hong JH, Hsueh S, Huang KG, Chou HH, et al. Randomized trial of neoadjuvant cisplatin, vincristine, bleomycin and radical hysterectomy versus radiation therapy for bulky IB and IIA cervical cancer. J Clin Oncol. 2000;18:1740-7.

Benedetti-Panici P, Greggi S, Colombo A, Amoroso M, Smaniotto D, Giannarelli D, et al. Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomized trial. J Clin Oncol. 2002;20:179-88.

Napolitano U, Imperato F, Mossa B, Framarino ML, Marziani R, Marzetti L. The role of neoadjuvant chemotherapy for squamous cell cervical cancer (Ib–IIIb): a longterm randomized trial. Eur J Gynaecol Oncol. 2003;24:51-9.

Eddy GL. Neoadjuvant chemotherapy before surgery in cervical cancer. J Natl Cancer Inst Monogr. 1996;(21):93-9.

Cai HB, Chen HZ, Yin HH. Randomized study of preoperative chemotherapy versus surgery for stage IB cervical cancer. J Obstet Gynecol Res. 2006;32:315-23.

Katsumata N, Yoshikawa H, Kobayashi H, Saito T, Kuzuya K, Nakanishi T, et al. Phase III randomized controlled trial of neoadjuvant chemotherapy plus radical surgery vs radical surgery alone for stages IB2, IIA2, and IIB cervical cancer: a Japan clinical oncology group trial (JCOG 0102). Brit J Cancer. 2013;108:1957-63.

Kim HS, Sardi JE, Katsumata N, Ryu HS, Nam JH, Chung HH, et al. Efficacy of neoadjuvant chemotherapy in patients with FIGO stage IB1 to IIA cervical cancer: an International collaborative meta-analysis. Eur J Surg Oncol. 2013;39:115-24.

Rydzewska L, Tierney J, Vale CL, Symonds PR. Neoadjuvant chemotherapy plus surgery versus surgery for cervical cancer. Cochrane Database Syst Rev. 2012;12:CD007406.

Neoadjuvant chemotherapy for locally advanced cervical cancer: a systematic review and meta-analysis of individual patient data from 21 randomised trials. Neoadjuvant chemotherapy for cervix cancer meta-analysis collaboration (NACCCMA Collaboration). Eur J Cancer. 2003;39:2470-86.

Neoadjuvant chemotherapy for cervical cancer meta-analysis (NACCCMA) collaboration: Neoadjuvant chemotherapy for locally advanced cervical cancer. Cochrane Database Syst Rev. 2004;2:CD001774.

Prakash G, Kumar L. Chemotherapy for cervical cancer: an update; in Rajaram S (ed): cancer cervix, ed 1. New Dehli, Jaypee Brothers Medical Publishers Pvt. Ltd.; 2011:215-221.